Phylogenetics

As per available reports about 58 journals, 37 Conferences, 22 workshops are presently dedicated exclusively to Phylogenetics and about 6350 articles are being published on the current trends in Phylogenetics. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to Phylogenetics are being carried out. Phylogenetics is the study of evolutionary interaction among group of organisms, which are revealed throughout molecular sequencing statistics and morphological statistics matrices. Phylogenetics derived from Greek terms phylé and phylon. The term "phylogeny" is derived from the German Phylogenie, introduced by Haeckel in 1866. Taxonomy, identification, classification, and naming of organisms - is generally informed by phylogenetics.

The Journal of Phylogenetics & Evolutionary Biology is an open access journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in Phylogenetics & Evolutionary researches. Journal of Phylogenetics & Evolutionary Biology is a scholarly Open Access journal and aims to publish the most complete and reliable source of information on the advanced and very latest research topics. The Journal of Phylogenetics & Evolutionary Biology is the field that deals with the study of evolutionary relations among groups of organisms and the computational simulation techniques for the study of biological, behavioral, and social systems.

OMICS International – a pioneering organizing international conferences. OMICS International officially welcomes the scientific community to attend the 2nd International Conference on Epidemiology & Evolutionary Genetics Conference. This International conference is an excellent opportunity for some of the major global health concerns which have brought huge attention in recent years are emerging infections, drug resistant strains, achieving vaccination goals, obesity/diabetes management, need for effective cancer screening and the diagnosis protocols, the impacts of Aging population, the measures to reduce the mortality and morbidity rates in reproductive and sexual health, call for efficient clinical trials and stringent drug safety measures.